-
LEADSPHERE® Proteinase K - A Freeze-Dried Reagent Optimized for POCT Devices
A Simple and Expedited Method for Viral RNA Extraction in Saliva using LEADSPHERE® Proteinase K.
-
Monkeypox Virus: A New Emergency to Humans
Monkeypox is caused by the monkeypox virus (MPXV), a DNA virus that belongs to the Orthopoxvirus genus which includes variola virus (smallpox) and cowpox virus. The MPXV can be classified into two major groups: Congo Basin Clade and West African Clade; the former clade has a case fatality rate of up to 10%
-
Quantitatively Detect Residual HRV 3C Protease in Your Samples!
Contact Leadgene now to inquire the brilliant ELISA kit and unblind your QC data.
-
Leadgene Glycerol-Free Products - The Ideal Materials for Your POCT Development!
Leadgene's glycerol-free series products provides flexibility for various conditions and are compatible with LEADSPHERE™ Lyophilization Technology.
-
Quality RUO-Grade Biosimilar Antibodies Are Now Available at Leadgene
Leadgene offers about two hundreds RUO-grade biosimilar antibodies.
-
SARS-CoV-2 (COVID-19) Omicron Variant Mutation Sites in Spike Protein
The Omicron differs structurally from all other variants that have been known, and compared to the wild-type Wuhan-Hu-1 strain, 32 out of 50 mutations are located on the spike protein.
-
Does Omicron Variant Cause Milder Symptoms?
Multiple research teams recently proposed another unique feature of the Omicron: the variant prefers entering cells by an endosomal route, similar to SARS-CoV, rather than driving receptor-dependent syncytium formation, catalyzed by surface TMPRSS2 protease.
-
New Choices for Your RT-qPCR and Isothermal PCR Experiments!
Compatible with Leadsphere® Lyophilization Technology for a lyophilized format (glycerol-free)
-
Biomolecular Interaction/Kinetic Measurement
It is imperative to explore and develop more efficient and comprehensive methods to further improve drug development processes and address the challenges posed by increasingly complex diseases.
-
The War in Immunotherapy: Current Advances in DC-CIK Therapy Against Cancer
During the past few decades, numerous efforts have been devoted to the field of immunotherapy to improve the efficacy and safety of conventional therapies, such as radiation and chemotherapy.
